MiR-133b showed a trend of gradual decline in its expression level as the disease progress from pre-atherosclerotic condition towards its more severe clinically progressive form, such as ACS, where it showed its lowest expression.
← all excerpts
Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease.
1
—
—